Renate Kruschitz

Renate Kruschitz

Auto-generated profile, based on publicly available information

Renate Kruschitz

Division of Endocrinology and Metabolism, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2016 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
MLMaria Luger
Maria Luger
RKRenate Kruschitz
Renate Kruschitz
CKChristian Kienbacher
Christian Kienbacher
STStefan Traussnigg
Stefan Traussnigg
FLFelix B. Langer
Felix B. Langer
BLBernhard Ludvik
Bernhard Ludvik
Background Bariatric patients often suffer from vitamin D deficiency (VDD), and both, morbid obesity and VDD, are related to non-alcoholic fatty liver disease. However, limited data are available regarding best strategies for treating VDD, particularly, in bariatric patients undergoing omega-loop gastric bypass (OLGB). Therefore, we examined the efficacy and safety of a forced vitamin D dosing regimen and intervention effects in liver fibrotic patients. Methods In this double-blind, randomized, placebo-controlled trial, 50 vitamin D-deficient patients undergoing OLGB were randomly assigned to receive, in the first month postoperatively, oral vitamin D3 (≤3 doses of 100,000 IU; intervention group) or placebo as loading dose (control group) with subsequent maintenance dose (3420 IU/day) in both groups until 6-month visit. Results Compared with control group, higher increase of 25(OH)D (67.9 (21.1) vs. 55.7 nmol/L (21.1); p = 0.049) with lower prevalence of secondary hyperparathyroidism (10 vs. 24 %; p = 0.045) was observed in intervention group. No (serious) adverse events related to study medication were found. The loading dose regimen was more effective in increasing 25(OH)D in patients with significant liver fibrosis while this was not the case for conventional supplementation (placebo with maintenance dose) (71.5 (20.5) vs. 22.5 nmol/L (13.8); p = 0.022; n = 14). Conclusions Our findings indicate that a high vitamin D3 loading dose, in the first month postoperatively, with subsequent maintenance dose is effective and safe in achieving higher vitamin D concentrations in OLGB patients. Unexpectedly, it is more effective in patients with significant liver fibrosis which is of potentially high clinical relevance and requires further investigation.

8 November 2014 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
MLMaria Luger
Maria Luger
RKRenate Kruschitz
Renate Kruschitz
FLFelix Langer
Felix Langer
GPGerhard Prager
Gerhard Prager
MWMelanie Walker
Melanie Walker
BLBernhard Ludvik
Bernhard Ludvik

2 July 2018 in Obesity Surgery
Verified
Journal Article
Open access
PDF file
MLMaria Luger
Maria Luger
RKRenate Kruschitz
Renate Kruschitz
EWEva Winzer
Eva Winzer
KSKarin Schindler
Karin Schindler
Igor GrabovacIgor Grabovac
Igor Grabovac
BLBernhard Ludvik
Bernhard Ludvik
Little is known about changes in bone mineral density (BMD) following weight loss after one-anastomosis gastric bypass (OAGB) and the role of serum vitamin D and its supplementation on bone metabolism. We evaluated BMD after OAGB as a function of vitamin D supplementation with respect to a minimum threshold of 25-hydroxy-vitamin-D [25(OH)D] concentration, which could prevent or decelerate an eventual bone loss.

1 May 2016 in Endocrine Practice
Verified
Journal Article
Closed access
PWPeter Wolf
Peter Wolf
WYWinhofer Yvonne
Winhofer Yvonne
SSSabina Smajis
Sabina Smajis
RKRenate Kruschitz
Renate Kruschitz
KSKarin Schindler
Karin Schindler
MKMichael Krebs
Michael Krebs

5 August 2015 in Trials
Verified
Journal Article
Open access
PDF file
MLMaria Luger
Maria Luger
RKRenate Kruschitz
Renate Kruschitz
RMRodrig Marculescu
Rodrig Marculescu
HHHelmuth Haslacher
Helmuth Haslacher
FHFriedrich Hoppichler
Friedrich Hoppichler
BLBernhard Ludvik
Bernhard Ludvik
Beyond its classical role in calcium homoeostasis and bone metabolism, vitamin D deficiency has been found to be associated with several diseases, including diabetes, non-alcoholic fatty liver disease, and even obesity itself. Importantly, there are limited data on therapeutic strategies for vitamin D deficiency in bariatric patients, and the procedure-specific guidelines may not be sufficient. To improve long-term outcomes, nutritional screening and appropriate supplementation to prevent nutrient deficiencies are urgently needed. Therefore, the aim of this study is to examine effects and safety of a forced dosing regimen of vitamin D versus conventional dose supplementation on vitamin D levels and other parameters in bariatric patients. The study includes loading plus repeat dosing compared with repeated administration of vitamin D without a loading dose, according to guidelines, in a prospective, double-blind, randomized controlled trial. Up to a triple oral loading dose is given on day 1, then 2 and 4 weeks after surgery (100,000 IU dose each time), followed by an oral maintenance dose (3420 IU/day). The control group (n = 25) will receive placebo, followed by administration of a standard dose (3420 IU/day). We hypothesize that a significant increase in vitamin D levels will occur in patients in the treatment group (n = 25) by 24 weeks after surgery. Further measurements are aimed at evaluating changes in inflammation, bone turnover, insulin resistance, blood pressure, liver, mental health, and gut microbiota of patients undergoing omega-loop gastric bypass surgery. Furthermore, possible associations between concentrations of vitamin D, the involved enzymes, or vitamin D receptor in adipose and/or liver tissues will be determined. To our knowledge, this trial is the first of its kind with this type of vitamin D supplementation in bariatric patients. Its major strength is the design and implementation of evaluation of influencing factors such as liver function, bone health, inflammation, insulin resistance, blood pressure, symptoms of depression, or microbiota. This alternative vitamin D dosing regimen has the potential to be a safe, fast, evidence-based treatment of vitamin D deficiency in bariatric patients. Owing to the increasing number of bariatric patients, it is also of interest to elucidate the link between obesity and vitamin D. ClinicalTrials.gov identifier: NCT02092376. Registered on 17 March 2014.